These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2253658)

  • 1. Effect of furosemide on angiotensin II-mediated prostaglandin I2 production in hypertensive subjects.
    Fujimura A; Ebihara A
    Eur J Clin Pharmacol; 1990; 39(2):113-5. PubMed ID: 2253658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of angiotensin II in renal prostaglandin E2 production after furosemide administration.
    Fujimura A; Ebihara A
    Hypertension; 1988 May; 11(5):491-4. PubMed ID: 3284821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of captopril on urinary excretion of furosemide in hypertensive subjects.
    Fujimura A; Shimokawa Y; Ebihara A
    J Clin Pharmacol; 1990 Jun; 30(6):538-42. PubMed ID: 2191978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of prostacyclin involvement in angiotensin-induced aldosterone secretion in rat adrenal cells.
    Campbell WB; Gomez-Sanchez CE
    Endocrinology; 1985 Jul; 117(1):279-86. PubMed ID: 3924581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The contribution of PGI2 to the effects of captopril in conscious dogs in differing states of sodium balance.
    Watson ML; Jones RL
    Clin Sci (Lond); 1986 Nov; 71(5):533-8. PubMed ID: 3533395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin II-induced hypertension in the rat. Effects on the plasma concentration, renal excretion, and tissue release of prostaglandins.
    Diz DI; Baer PG; Nasjletti A
    J Clin Invest; 1983 Aug; 72(2):466-77. PubMed ID: 6575977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary 6-keto-PGF1 alpha after captopril and indomethacin: possible contribution of PGI2 to the antihypertensive mechanism of ACE inhibitors.
    Minuz P; Degan M; Covi G; Lechi C; Velo GP; Lechi A
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():199-202. PubMed ID: 2988309
    [No Abstract]   [Full Text] [Related]  

  • 8. Short-term increase in prostaglandin I2 synthesis caused by cicletanine in patients with essential hypertension.
    Yasu T; Imanishi M; Kimura G; Tsuji T; Matsuoka H; Kuramochi M; Omae T
    Am J Hypertens; 1995 Sep; 8(9):944-8. PubMed ID: 8541011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of captopril on urinary 6-keto-PGF1 alpha, thromboxane B2 in inbred SHR rats].
    Wang L
    Zhonghua Xin Xue Guan Bing Za Zhi; 1991 Dec; 19(6):385-7, 398. PubMed ID: 1821358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response of urinary angiotensin to challenges of the renin-angiotensin system.
    Boer P; Vos PF; Koomans HA; Rabelink AJ; Beutler JJ; Dorhout Mees EJ
    Clin Chim Acta; 1991 Jun; 199(2):195-204. PubMed ID: 1873917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of tienoxolol, a new diuretic beta-blocking agent, on urinary prostaglandin excretion in the rat.
    Caussade F; Cloarec A
    Br J Pharmacol; 1993 May; 109(1):278-84. PubMed ID: 8098641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Preliminary study on plasma 6-keto-prostaglandin F1 alpha levels before and after induction by furosemide in hypertensive patients].
    Zhao GS; Yuan XY; Shen XY
    Zhonghua Xin Xue Guan Bing Za Zhi; 1987 Jun; 15(3):134-6, 190. PubMed ID: 3325249
    [No Abstract]   [Full Text] [Related]  

  • 13. The antihypertensive action of hydrochlorothiazide and renal prostacyclin.
    Wilson TW
    Clin Pharmacol Ther; 1986 Jan; 39(1):94-101. PubMed ID: 3510798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin II-stimulated prostaglandin production by canine renal afferent arterioles.
    Hura CE; Kunau RT
    Am J Physiol; 1988 May; 254(5 Pt 2):F734-8. PubMed ID: 3284391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of indomethacin on hormonal and blood pressure responses to captopril in spontaneously hypertensive rats.
    Säynävälammi P; Arvola P; Kuismanen K; Seppälä E; Nurmi AK; Manninen V; Vapaatalo H
    Pharmacol Toxicol; 1987 Sep; 61(3):195-8. PubMed ID: 3317383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the effect of two angiotensin-converting enzyme inhibitors, captopril and cilazapril, on platelet and vascular prostaglandin metabolism in vivo.
    Wagner B; Eichler HG; Schneider B; Blöchl-Daum B; Brenner B; Gasic S; Lechner K; Kyrle PA
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Oct; 346(4):453-6. PubMed ID: 1436129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of captopril on urinary excretion of prostaglandins and renin-angiotensin-aldosterone system in normal subjects.
    Zacharieva S; Koev D; Andonova K
    Acta Physiol Pharmacol Bulg; 1989; 15(4):25-30. PubMed ID: 2699540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of PGE2, 6-keto PGF1 alpha and renin release from dog kidneys.
    Bugge JF; Vikse A; Dahl E; Slørdahl SH; Kiil F
    Acta Physiol Scand; 1986 Jun; 127(2):197-205. PubMed ID: 3088915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of captopril-induced renin release by angiotensin II.
    Mersey JH; Ceballos L; Swartz S
    J Cardiovasc Pharmacol; 1987 Nov; 10(5):575-9. PubMed ID: 2447408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frusemide, ACE inhibition, renal dopamine and prostaglandins: acute interactions in normal man.
    MacDonald TM; Craig K; Watson ML
    Br J Clin Pharmacol; 1989 Dec; 28(6):683-94. PubMed ID: 2532921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.